ATEA PHARMACEUTICALS, INC. — Income Charts
1 years of history · ending 2021-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$351M
R&D
$167M
D&A
$29K
Operating Income
$138M
EBITDA
$138M
Other Income/Expense
$213K
Pretax Income
$139M
Tax Provision
$17M
Net Income
$121M
Operating Margin
39.4%
Net Margin
34.5%
Effective Tax Rate
12.6%
Deferred Tax Assets
$0
DTA Valuation Allowance
$11M
Tax Credit Carryforwards
—
NOL Carryforwards
—
ETR (Continuing Operations)
12.5%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
3.2%
Operating Lease Cost
$281K
Revenue YoY Variation
622.5%
Income YoY Variation
1354.6%